Comparing the Two Top Stocks: Neptune Technologies & Bioresources Inc (NASDAQ:NEPT), Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Neptune Technologies & Bioresources Inc (NASDAQ:NEPT)

Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) closed at $2.15 on the last trading session with an increase of 1.9%, whereas, it previously closed at $2.11. The company has a market capitalization of $239.88 Million. The company traded shares of 196702 on the trading day while its three month average volume stands at 683.12 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) produced diluted EPS of 0. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 0, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) stands at 0 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) stands at 0, 0 and 0 respectively

The trailing twelve month Revenue of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) is reported at 0 with income of 0. The outstanding shares of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) are 111.57 Million. The institutional Ownership of the shares of 19.17 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) is ticked at 17.5%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) is the Mean Target Price estimated by the analysts which stands at 0. The 52 week high of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) is placed at 3.96 and 52 week low is standing at 0.96.

Performance wise the shares of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) fell down -9.66% for the week, it also fell -24.03% for the monthly performance, while for the quarter it went up -23.21%. The shares increase 83.76% for the half year and plummeted for the Year-To-Date performance. The shares of Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) shrinked -39.61% for the yearly performance.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) closed at $10.81 on the last trading session with an decrease of -0.92%, whereas, it previously closed at $10.91. The company has a market capitalization of $550.99 Million. The company traded shares of 145012 on the trading day while its three month average volume stands at 384.22 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) produced diluted EPS of -1.5. The EPS estimate for next year as estimated by analysts is at -1.19 while EPS for next quarter is estimated at -0.33. Earnings per Share growth for this year is reported at 4.6, while the analysts estimated the EPS growth for next year at -1.19% and Earnings growth for next 5 years stands at 30% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -16.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) stands at 54.02 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) are reported at 9.3 and 10.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) stands at -63.7, 576.7 and -59.3 respectively

The trailing twelve month Revenue of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is reported at 10.2 Million with income of -82300000. The outstanding shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) are 55.45 Million. The institutional Ownership of the shares of 52.4 stands at 0.80%, this figure is decreased -3.14 in the last six months. The insider ownership for the shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is ticked at 0.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is the Mean Target Price estimated by the analysts which stands at 19. The 52 week high of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is placed at 19.22 and 52 week low is standing at 4.53.

Performance wise the shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell down -3.05% for the week, it also fell -10.36% for the monthly performance, while for the quarter it went up -28.69%. The shares increase 29.77% for the half year and plummeted for the Year-To-Date performance. The shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shrinked -41.79% for the yearly performance.